Treatment-induced damage to the tumor micro-environment promotes cancer therapy resistance through extracellular proteins
US9759725B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2013 |
| Grant date | Sep 12, 2017 |
| Priority date | — |
| Expiry date | Aug 2, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/60
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides methods for determining the effectiveness of a cancer therapy, as well as methods for increasing the effectiveness of that therapy and determining a prognosis for a patient receiving that therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.